Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol versus ondansetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy
IRCT20141009019470N85Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of haloperidol and ondansetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Postoperative nausea and vomiting, Length of stay in recovery room and 1 more. Started Aug 2019; status: completed.
02
Drugs
haloperidolondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20141009019470N85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N85.